English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Narrowing of the lumen of the renal artery is termed renal artery stenosis (RAS) and can be a cause of hypertension and chronic kidney disease (CKD).1 When hypertension is caused by RAS the term renovascular hypertension is used, but the only way to be certain of the diagnosis is to demonstrate that relief of the renal artery narrowing results in a return to a normal blood pressure. This is because essential hypertension is considerably more common than, and a risk factor for, RAS so the coexistence of RAS and hypertension in a patient does not infer causality. In addition, even where clinically significant RAS is the initial cause of hypertension, reversal of the stenosis may not result in a normal blood pressure or renal function if longstanding hypertension has produced irreversible contralateral renal injury.2RAS is most commonly due to atherosclerotic renal artery stenosis (ARAS) and has been reported to be present in around 30% of patients having routine coronary angiography and up to 50% of patients undergoing peripheral angiography.2 The presence and anatomical location of RAS can be confirmed by non-invasive imaging with duplex ultrasound, …

New guidelines for drive-by renal arteriography may lead to an unjustifiable increase in percutaneous intervention